CHRS Net Income
Coherus Oncology Inc · Net Income
CHRS Net Income
Latest reported-$130.96Mperiod ending
CHRS TTM Net Income (-$53.64M → -$130.96M)
TTM net income
High-resolution chart · PNG
CHRS net income history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Net Income (USD) |
|---|---|
| -130,957,000 | |
| -151,661,000 | |
| -170,291,000 | |
| -183,709,000 | |
| -159,351,000 | |
| -130,937,000 | |
| 28,507,000 | |
| -450,000 | |
| -29,340,000 | |
| -59,288,000 | |
| -237,892,000 | |
| -217,109,000 | |
| -264,118,000 | |
| -271,399,000 | |
| -291,754,000 | |
| -278,609,000 | |
| -230,487,000 | |
| -210,237,000 | |
| -287,100,000 | |
| -231,667,000 | |
| -165,206,000 | |
| -76,275,000 | |
| 132,244,000 | |
| 161,763,000 | |
| 180,873,000 | |
| 145,409,000 | |
| 89,833,000 | |
| -11,990,000 | |
| -117,841,000 | |
| -185,046,000 | |
| -209,339,000 | |
| -195,810,000 | |
| -195,991,000 | |
| -207,689,000 | |
| -238,170,000 | |
| -265,024,000 | |
| -122,096,000 | |
| -136,727,000 | |
| -127,337,000 | |
| -103,807,000 | |
| -259,080,000 | |
| -247,923,000 | |
| -223,260,000 | |
| -200,003,000 | |
| -136,541,000 | |
| -102,688,000 | |
| -87,133,000 | |
| -72,590,000 | |
| -86,191,000 | |
| -69,943,000 | |
| -53,635,000 |